Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors

Hypertension Research

Volumn 34, Issue 2, 2011, Pages 212-217

  Hirashima, Chikako ^a   Ohkuchi, Akihide ^a,b   Takahashi, Kayo ^a   Suzuki, Hirotada ^a   Yoshida, Mika ^a   Ohmaru, Takako ^a   Eguchi, Kazuo ^a   Ariga, Haruko ^a   Matsubara, Shigeki ^a   Suzuki, Mitsuaki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Haga Red Cross Hospital   (Japan)

Author keywords

gestational hypertension; placental growth factor; preeclampsia; soluble endoglin; soluble fms like tyrosine kinase 1

Indexed keywords

ANGIOGENIC FACTOR; ENDOGLIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; DISEASE COURSE; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MORBIDITY; PREECLAMPSIA; PROTEIN BLOOD LEVEL; PROTEINURIA;

ADULT; ANGIOGENESIS INDUCING AGENTS; ANTIGENS, CD; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; RECEPTORS, CELL SURFACE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79751475694     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.212     Document Type: Article

References (21)

1. Hypertension (PIH)' (2004) In Japan Society for the Study of Toxemia of Pregnancy (ed) Historical Perspective of Study of Pregnancy-Induced Hypertension in Japan 2005, pp 54-87.
2. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
3. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: IX-XIV. (Pubitemid 32672922)
4. Morikawa M, Yamada T, Yamada T, Cho K, Yamada H, Sakuragi N, Minakami H. Pregnancy outcome of women who developed proteinuria in the absence of hypertension after mid-gestation. J Perinat Med 2008; 36: 419-424.
5. Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hypertension become preeclampsia? Br J Obstet Gynaecol 1998; 105: 1177-1184. (Pubitemid 28526200)
6. Barton JR, O'brien JM, Bergauer NK, Jacques DL, Sibai BM. Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 2001; 184: 979-983. (Pubitemid 32368119)
7. Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba'aqeel H, Farnot U, Bergsjø P, Bakketeig L, Lumbiganon P, Campodónico L, Al-Mazrou Y, Lindheimer M, Kramer M, World Health Organization Antenatal Care Trial Research Group. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 2006; 194: 921-931.
8. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683. (Pubitemid 38364626)
9. Hirashima C, Ohkuchi A, Arai F, Takahashi K, Suzuki H, Watanabe T, Kario K, Matsubara S, Suzuki M. Establishing reference values for both total soluble Fms-like tyrosine kinase 1 and free placental growth factor in pregnant women. Hypertens Res 2005; 28: 727-732. (Pubitemid 41723531)
10. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992-1005. (Pubitemid 44343543)
11. Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Arai F, Watanabe T, Kario K, Suzuki M. Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res 2007; 30: 151-159. (Pubitemid 46541789)
12. Hirashima C, Ohkuchi A, Matsubara S, Suzuki H, Takahashi K, Usui R, Suzuki M. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset. Hypertens Res 2008; 31: 1541-1548.
13. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12: 642-649. (Pubitemid 43865232)
14. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658. (Pubitemid 36278583)
15. Suzuki H, Ohkuchi A, Matsubara S, Takei Y, Murakami M, Shibuya M, Suzuki M, Sato Y. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice. Hypertension 2009; 54: 1129-1135.
16. Salahuddin S, Lee Y, Vadnais M, Sachs BP, Karumanchi SA, Lim KH. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. Am J Obstet Gynecol 2007; 197: 28.e1-28.e6.
17. Ogawa Y, Iwamura T, Kuriya N, Nishida H, Takeuchi H, Yakada M, Itabashi K, Imura S, Isobe K. Birth size standards by gestational age for Japanese neonates. Acta Neonatologica Japonica 1998; 34: 624-632.
18. Harris EK, Boyd JC. Time-dependent reference values, In Harris EK, Boyd JC (eds) Statistical Bases of Reference Values in Laboratory Medicine. Marcel Dekker Inc: New York, 1995, pp 149-186.
19. Strevens H, Wide-Swensson D, Hansen A, Horn T, Ingemarsson I, Larsen S, Willner J, Olsen S. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 2003; 110: 831-836. (Pubitemid 37159268)
20. Davis GK, Mackenzie C, Brown MA, Homer CS, Holt J, McHugh L, Mangos G. Predicting transformation from gestational hypertension to preeclampsia in clinical practice: a possible role for 24 h ambulatory blood pressure monitoring. Hypertens Pregnancy 2007; 26: 77-87. (Pubitemid 46649345)
21. Valensise H, Vasapollo B, Novelli GP, Pasqualetti P, Galante A, Arduini D. Maternal total vascular resistance and concentric geometry: a key to identify uncomplicated gestational hypertension. BJOG 2006; 113: 1044-1052. (Pubitemid 44310097)